PF-3758309
|
|
- CAS-Nr.
- 898044-15-0
- Englisch Name:
- PF-3758309
- Synonyma:
- X4Z;PF-309;CS-1014;PF-3758309;PF-03758309;PF 3758309;PF3758309;PF-3758309 USP/EP/BP;PF-03758309/PF03758309;p21-Activated Kinase Inhibitor II, PF-3758309 - CAS 898044-15-0 - Calbiochem;N-[(1S)-2-(Dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl
- CBNumber:
- CB32624276
- Summenformel:
- C25H30N8OS
- Molgewicht:
- 490.62
- MOL-Datei:
- 898044-15-0.mol
|
PF-3758309 Eigenschaften
- Dichte
- 1.325±0.06 g/cm3(Predicted)
- storage temp.
- -20C
- L?slichkeit
- ≥24.53 mg/mL in DMSO; insoluble in H2O; ≥101.4 mg/mL in EtOH with gentle warming and ultrasonic
- Aggregatzustand
- Yellowish-white powder
- pka
- 12.82±0.40(Predicted)
- Farbe
- White to light yellow
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H317 |
Kann allergische Hautreaktionen verursachen. |
Sensibilisierung der Haut |
Kategorie 1A |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
|
Sicherheit |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
|
PF-3758309 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
PF-3758309 is a pyrrolopyrazole inhibitor of PAK4 (p21-activated kinase). It is used in biological studies for targeting Rho GTPase signaling for cancer therapy.
PF-3758309 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
PF-3758309 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 82)Lieferanten
- PF-3758309
- (S)-N-(2-(diMethylaMino)-1-phenylethyl)-6,6-diMethyl-3-((2-Methylthieno[3,2-d]pyriMidin-4-yl)aMino)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxaMide
- PF-03758309/PF03758309
- N-[(1S)-2-(Dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide
- PF-03758309
- Pyrrolo[3,4-c]pyrazole-5(1H)-carboxaMide, N-[(1S)-2-(diMethylaMino)-1-phenylethyl]-4,6-dihydro-6,6-diMethyl-3-[(2-Methylthieno[3,2-d]pyriMidin-4-yl)aMino]-
- N-[(1S)-2-(Dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide PF 3758309
- X4Z
- N-[(1S)-2-(Dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl
- (S)-N-(2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno[3,2-d]pyrimidin-4-yl)a
- CS-1014
- N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide
- p21-Activated Kinase Inhibitor II, PF-3758309 - CAS 898044-15-0 - Calbiochem
- PF 3758309;PF3758309
- PF-309
- PF-3758309 USP/EP/BP
- proliferation,tumor,PF-3758309,oncogenic,survival,PF03758309,PF3758309,inhibit,p21 activated kinases,signaling,Apoptosis,ATP-competitive,Inhibitor,PF 03758309,growth,PAK
- 898044-15-0
- C25H30N8OS
- Inhibitors